Recombinant TNFRSF8 (Brentuximab Biosimilar) antibody
This Chimeric Chimeric antibody specifically detects TNFRSF8 (Brentuximab Biosimilar) . It exhibits reactivity toward Human.
Catalog No. ABIN7597566
$357.68
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 15 Business Days
Quick Overview for Recombinant TNFRSF8 (Brentuximab Biosimilar) antibody (ABIN7597566)
Target
TNFRSF8 (Brentuximab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Chimeric
Clonality
Chimeric
Conjugate
This TNFRSF8 (Brentuximab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Brentuximab Biosimilar Antibody
-
Specificity
- CD30L receptor, Ki-1 antigen, CD30, TNFRSF8, D1S166E, Tumor necrosis factor receptor superfamily member 8, Lymphocyte activation antigen CD30
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1 kappa
-
-
anti-TNFRSF8 (Brentuximab Biosimilar) antibody
Research Grade Reactivity: Human ELISA Host: Mouse Chimeric unconjugated Recombinant Antibody
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- TNFRSF8 (Brentuximab Biosimilar)
-
Alternative Name
- Brentuximab Biosimilar
-
Target Type
- Biosimilar
-
Background
- CD30L receptor, Ki-1 antigen, CD30, TNFRSF8, D1S166E, Tumor necrosis factor receptor superfamily member 8, Lymphocyte activation antigen CD30
-
UniProt
- P28908
-
CAS-No
- 914088-09-8
Target
-
You are here:
